FDA Approves Morphine Sulfate Oral Solution for Relief of Acute
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain
The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL.